Indo US Bio-Tech Limited confirms the successful processing of securities for dematerialization up to December 31, 2024, ensuring they have been accepted by depositories and listed on the appropriate stock exchange. All received certificates have been duly verified, mutilated, and cancelled within the prescribed timeframe, with registered ownership updated in member records. This operational efficiency may enhance shareholder confidence and streamline trading activities, reflecting positively on the company’s governance and operational integrity. Investors may view this as a commitment to maintaining robust operational procedures, potentially fostering a positive sentiment.